ADM’s Crushing Segment Faces Supply-Squeeze Trade as EPA Mandate Sparks 60% Biofuel Demand Surge

The new EPA rule sets a concrete, enforceable demand for biofuels, creating a clear supply-demand imbalance for ADM's core business. The final rule mandates a record 25.82 billion gallons of biofuels to be blended into the fuel supply for 2026, an 8% increase from the proposed level. This is not a vague target; it translates directly into a specific volume requirement for the key product ADM produces. For biomass-based diesel, the rule establishes a 2026 requirement of 8.86 billion RINs, with a total applicable volume of 9.07 billion RINs after accounting for a reallocation of small refinery exemptions (SREs).

The critical pressure point is the 70% reallocation of SREs granted for 2023-2025. This means a significant portion of the compliance burden that was previously waived from small refiners is now being shifted onto the broader refining sector. The rule explicitly states it partially waives the 2025 cellulosic biofuel volume requirement and revises standards due to a shortfall, but the SRE reallocation directly increases the total volume of RINs that refiners must acquire and surrender. This creates a surge in demand for physical biodiesel and renewable diesel, as refiners scramble to meet their obligations.

The scale of the required expansion is immense. EPA estimates that to meet these historic 2026 volumes, biodiesel and renewable diesel production and use will need to increase by over 60 percent compared to 2025 volumes. This is the core of the imbalance. The mandate provides a strong, long-awaited demand signal, but the physical supply chain-spanning feedstock cultivation, conversion capacity, and logistics-must now ramp up at an unprecedented pace. The thesis is that the EPA's final rule delivers the policy clarity ADM needed, but the critical question for the company is whether this physical supply can be built fast enough to meet the mandated volumes without triggering severe price spikes in both the biofuel and its feedstock inputs.

ADM's Supply Position: Capacity, Costs, and the Crushing Segment

The new mandate creates a powerful demand signal, but ADM's ability to supply the required volumes hinges on its crushing operations and the broader feedstock market. The company's recent financials show a business under structural pressure. For full-year 2025, the Crushing segment's operating profit collapsed 81%, a direct result of weak soybean oil demand tied to unresolved biofuel blending quotas weak soybean oil demand tied to unresolved U.S. biofuel blending quotas. This isn't a capacity issue; management noted the segment set a record global crush volumes even as margins were crushed. The operational infrastructure is there, but the cash flow was absent.

The mandate now provides the missing piece: a guaranteed buyer for soybean oil and other feedstocks. This should allow ADM to capture higher margins as it processes more volume. However, the company's recent Q4 2025 earnings beat was driven by strong results in Nutrition and Oilseeds, not Crushing strong results in Nutrition and Oilseeds. The segment remains a significant vulnerability, and the path to margin recovery is contingent on the policy resolution that management has flagged as the key catalyst for 2026.

The structural constraint lies in the feedstock market itself. The mandate requires a 60 percent increase in biodiesel and renewable diesel production from 2025 levels. This surge in demand for oils and fats will inevitably pressure feedstock costs. ADM, as a major processor, will need to secure these inputs competitively. The company's scale and global footprint give it an advantage, but the sheer volume of new demand could tighten supply and compress margins if not managed carefully. The risk is that the cost of feedstocks rises faster than the company can pass through higher biofuel prices, squeezing the very margins the mandate is meant to unlock.

The bottom line is one of potential and peril. The policy clarity removes a major overhang, and ADM's crushing capacity is ready to ramp. But the company's recent history shows how quickly those margins can vanish without a stable demand environment. The new mandate provides that stability, but ADM must now execute on securing feedstocks and converting its processing power into profitable output at a time when the entire supply chain is under strain to expand.

Valuation and Market Pricing: A Discount or Fair Price?

The market has clearly reassessed the policy risk, with ADM shares recovering from a 52-week low to trade around $69. This rebound reflects a shift in sentiment from uncertainty to anticipation of the new mandate's benefits. Yet the valuation picture remains mixed, suggesting the market is still weighing the promise of the supply-demand shift against execution risks and the company's recent operational struggles.

On one hand, the stock's recovery to near its high for the year indicates strong conviction that the policy clarity will unlock value. The company's recent Q4 2025 earnings beat, driven by Nutrition and Oilseeds, provided a floor for the stock while the market digested the biofuel news shares recovering to $69.39 after crashing to a 52-week low of $40.98. On the other hand, analyst models appear cautious. The average price target sits at $62.09, implying a discount to the current price. A widely followed fair value estimate of about $60.73 further underscores this skepticism, with the narrative framing the stock as potentially 9% Overvalued based on steady revenues and modest margin shifts.

The core tension is between a high trailing P/E ratio of 27.14 and the expectation of accelerated earnings growth. The market is paying a premium for future growth, but that growth is contingent on the physical supply chain meeting the mandate's 60% production increase biodiesel and renewable diesel production and use will need to increase by over 60 percent. If ADM can successfully convert its crushing capacity into higher margins, the valuation may be justified. If feedstock costs rise faster than biofuel prices, or if capacity expansions lag, the premium could compress.

The primary catalyst for a re-rating is execution. Investors should watch for three key signals in the coming weeks: the trajectory of Renewable Identification Number (RIN) prices, which will reflect compliance pressure; ADM's own crushing margins in its upcoming Q1 2026 results; and any announcements of new biofuel capacity expansions, like the recent plans by rival Gevo Gevo Inc. on March 30 announced that it is developing plans for a potential expansion. For now, the market is pricing in the mandate's potential but demanding proof that ADM can deliver the supply to meet it.

Risks and Counterpoints: Refiner Pushback and Production Limits

The mandated demand surge is not guaranteed to flow smoothly into ADM's profits. Two major risks could blunt the policy's impact: industry pushback and physical production limits.

First, the increased compliance burden on refiners may trigger legal or political challenges. The rule's 70% reallocation of small refinery exemptions (SREs) is a direct transfer of cost, creating a powerful incentive for affected parties to contest the implementation. While the administration frames the rule as historic and supportive of farmers, the financial pressure on refiners is real. Any successful legal action or political reversal could delay or dilute the demand signal, undermining the investment case for rapid capacity expansion.

Second, and more fundamental, is the physical constraint of production capacity. The industry is planning expansions, as seen with Gevo's plans to build a potential expansion at its North Dakota facility, but new plants take years to permit and construct. The mandate requires a 60 percent increase in biodiesel and renewable diesel production from 2025 levels. This is an enormous ramp-up that strains the entire supply chain, from feedstock to conversion to logistics. Even with ADM's crushing capacity ready, the company's ability to profit hinges on whether this physical expansion can keep pace with the mandated volumes. A bottleneck at any stage could lead to severe price spikes in both the biofuel and its feedstocks, compressing margins for processors.

The key uncertainty for ADM's bottom line is whether its crushing margins will improve enough to offset the costs of increased RIN purchases required for compliance. The company's recent history shows how quickly those margins can vanish without stable demand. While the mandate provides that demand, the cost of securing compliance RINs is a new and growing expense. If the price of RINs spikes due to tight supply, it could eat into the higher biofuel prices ADM expects to capture. The company's scale and global footprint are advantages, but they do not eliminate the fundamental tension between a policy-driven demand surge and a supply chain that must expand at record speed.